Jay A. Moore

Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response

Meagan Montesion, Karthikeyan Murugesan, Dexter X. Jin et al. · Cancer Discovery · 2020 · 231 citations · Full text

Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation

Smruthy Sivakumar, Jay A. Moore, Meagan Montesion et al. · Cancer Discovery · 2023 · 123 citations · Full text

Homozygous inactivation of <i>WTI</i> in a Wilms' tumor associated with the WAGR syndrome

Manfred Gessler, Anja König, Jay A. Moore et al. · Genes Chromosomes and Cancer · 1993 · 32 citations

The Molecular Landscape of Pancreatobiliary Cancers for Novel Targeted Therapies From Real-World Genomic Profiling

Kumiko Umemoto, Hiroyuki Yamamoto, Ritsuko Oikawa et al. · JNCI Journal of the National Cancer Institute · 2022 · 25 citations · Full text

Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response

Jay A. Moore, Kuei‐Ting Chen, Russell W. Madison et al. · JCO Precision Oncology · 2023 · 21 citations · Full text